Anti-VEGF Antibody HuMV833: an EORTC Biological Treatment Development Group Phase I Toxicity, Pharmacokinetic and Pharmacodynamic Study.
暂无分享，去创建一个
G. Jayson | M. Ranson | G. Groenewegen | P. Julyan | D. Hastings | A. Jackson | H. Haroon | J. Wagstaff | J. Zweit | F. Lehmann | A. McGown | D. Levitt | J. Lawrance | L. Hakannson | T. Tang | C. Mulatero | H. Zweirzina